Choroidal neovascularization
MONDO:0810000An eye disorder described by the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space. Choroidal neovascularization (CNV) is a major cause of visual loss.
26 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New eye drug trial aims to save sight in Hard-to-Treat AMD
Disease control Not yet recruitingThis study tests faricimab, a drug injected into the eye, for people with type 3 wet age-related macular degeneration (AMD), a condition that can cause rapid vision loss. Over 76 weeks, 30 participants will receive initial monthly doses, then a personalized schedule where injecti…
Phase: PHASE4 • Sponsor: Kim's Eye Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New eye scanner could spot hidden signs of blindness
Diagnosis Not yet recruitingThis study will test a new, non-invasive eye scanner called wide field OCTA in 200 people with various eye diseases, including age-related macular degeneration, diabetic retinopathy, and dry eye. The goal is to see if this device can provide better images of blood vessels in the …
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
AI model aims to predict which patients with Nearsightedness-Related eye damage will respond to standard therapy
Knowledge-focused Not yet recruitingThis study will follow 110 people with myopic choroidal neovascularization (mCNV), a complication of severe nearsightedness that can cause vision loss. Researchers will use deep learning to analyze eye scan images and build a model that predicts how well patients respond to anti-…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC